USPTO Will Confirm Key Lipitor Patent: Pfizer
Pfizer Inc. said Wednesday that the U.S. Patent and Trademark Office will confirm the patentability of one of its key patents for the cholesterol drug Lipitor....To view the full article, register now.
Already a subscriber? Click here to view full article